Amplifica Announces New Compound AMP-303
June 29, 2023
Amplifica has been very active in the first half of 2023. They announced the addition of SCUBE 3 (AMP-601) to their pipeline back in January, and announced osteopontin (AMP-203) in June as another compound discovered from Maksim Plikus’ research into hairy moles and hair growth. Now, just a week after the AMP-203 announcement, Amplifica has issued a press release for the initiation of a clinical trial for new mystery compound AMP-303. The front page and Articles page has the full Amplifica story.